Business Information
The group's principal activities are to develop, manufacture and sell products derived from microalgae. These products include specialty, nutritional oils for infant formula; nutritional supplements and food ingredients to promote mental and cardiovascular health; fluorescent markers for diagnostics, rapid miniaturized screening and gene and protein detection. The group also develops new fluorescent detection products from microalgae that connect fluorescent algal proteins to antibodies. The trademarks of the group include neuromins (R), dha gold (R), dhasco (R), and arasco (r).
|
|
Name |
Title
|
Email
|
| Robert Flanagan | Chmn. | N/A | | David Abramson | Pres. | N/A | | Steve Dubin | Dir., CEO | N/A | | Peter Nitze | COO, Sr. VP | N/A | | Tim Fealey | Sr. VP, Chief Innovation Officer | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 270,654 | 14,938 | | 2005 | 217,852 | 15,284 | | 2004 | 184,493 | 47,048
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
